University of Wolverhampton
Walsall, West Midlands, WS1 3BD, United Kingdom
NCT Number: NCT03463642
To test the efficacy of different vitamin D delivery methods on serum 25(OH)D. Participants randomly assigned to one of seven groups - three placebo groups and 4 active supplement groups receiving 100,000IU vitamin D3
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Walsall, West Midlands, WS1 3BD, United Kingdom
Various delivery methods of vitamin D supplementation are available to consumers but there have been no studies providing evidence of whether one delivery method is superior to others. The researchers wanted to compare the delivery of 100,000IU vitamin D3 by three methods on serum 25(OH)D levels. Two methods of oral supplementation (pill [prolonged release] and liquid [immediate release]), and delivery through the skin (with and without a penetrator enhancer. Placebo groups were pill, oral liquid and skin applied oil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100,000IU
Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate
100 drops orange syrup
Paraffinum Liquidum,Isopropyl Palmitate,Parfum
Tangerine essential oil (10ml)
Time frame: 4 weeks
Changes in serum 25(OH)D levels
University of Wolverhampton
Other
The Efficacy of Different Vitamin D Supplementation Delivery Methods on Serum 25(OH)D in Humans a Randomised Double-blind Placebo Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631312
Anemia, Anemia, Hypochromic
Atlanta, Georgia, United States
View Trial DetailsNCT06700122
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT06654063
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT07481240
Avitaminosis, Deficiency Diseases
Cork, Co. Cork, Ireland
View Trial Details